Logo

American Heart Association

  39
  0


Final ID:

Discussant: OPTIMA-AF trial

  • Patel, Manesh  ( DUKE MEDICAL CENTER , Durham , North Carolina , United States )
  • Author Disclosures:
    Manesh Patel: DO have relevant financial relationships ; Consultant:Bayer:Past (completed) ; Consultant:Janssen:Past (completed) ; Consultant:Esperon:Past (completed) ; Researcher:Idorsia:Active (exists now) ; Researcher:Regeneron:Active (exists now) ; Researcher:Bayer:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Dilemmas in Antithrombotic Therapy in AF Care Post Procedures

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Late-Breaking Science

More abstracts on this topic:
Discussant: CLOSURE-AF

Healey Jeff

Left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding compared to medical therapy (CLOSURE-AF)

Landmesser Ulf, Jacobshagen Claudius, Meder Benjamin, Zeiher Andreas, Anker Stefan, Thiele Holger, Blankenberg Stefan, Massberg Steffen, Schunkert Heribert, Frey Norbert, Joost Alexander, Skurk Carsten, Bergmann Martin, Haeusler Karl Georg, Endres Matthias, Wegscheider Karl, Boldt Leif-hendrik, Eitel Ingo, Kirchhof Paulus, Lewalter Thorsten, Hartung Johannes, Rroku Andi, Pieske Burkert, Brachmann Johannes, Akin Ibrahim

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available